Pharmaids Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

35.27

21.44

10.27

10.27

10.27

Share application money

-

0.35

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

35.79

0.63

-1.60

-1.74

-1.84

Loan funds

Secured loans

12.50

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

83.56

22.43

8.67

8.53

8.43

Uses of funds

Fixed assets

Gross block

16.61

0.12

0.51

0.51

0.51

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.06

0.02

0.48

0.47

0.42

Net block

16.55

0.11

0.03

0.04

0.08

Capital work-in-progress

2.30

2.00

0.45

0.45

0.45

Investments

52.60

3.27

-

-

-

Net current assets

Current assets, loans & advances

13.56

19.18

10.63

8.63

7.93

Less : current liabilities & provisions

1.44

2.13

2.44

0.59

0.03

Total net current assets

12.12

17.05

8.19

8.04

7.90

Miscellaneous expenses not written

-

-

-

-

-

Total

83.56

22.43

8.67

8.53

8.43

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

352.68

214.86

103.11

103.11

103.11